In anticipation of the February results season, Morgans previews all stocks under coverage. The broker settles upon key stock buy ideas to guide investors toward expected positive price reactions. The broker also highlight a few stocks with a difficult outlook.
Unfortunately
The broker forecasts around 5% earnings (EBITDA) growth for
Morgans also expects a strong performance from the domestic patent filing market with growth of 10.8% on the previous corresponding period.
The analyst estimates an interim dividend of
The Add rating and target of
Sector: Commercial & Professional Services.
Target price is
© 2021 Acquisdata Pty Ltd., source